| For: | Qi HX, Wang Q, Zhou GQ. Association of Clostridium difficile infection with clinical outcomes of patients with inflammatory bowel disease: A meta-analysis. World J Gastrointest Surg 2025; 17(4): 100555 [PMID: 40291861 DOI: 10.4240/wjgs.v17.i4.100555] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v17/i4/100555.htm |
| Number | Citing Articles |
| 1 |
Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, Domenico Morano, Felice Imoletti, Nadia Marascio, Marta Pantanella, Evelina Suraci, Raffaella Marasco, Maria Imeneo, Francesca Serapide, Enrico Maria Trecarichi, Alessandro Russo, Angela Quirino, Ludovico Abenavoli, Giovanni Matera, Francesco Luzza. Clostridioides difficile infection increases the need for using biologics in patients with inflammatory bowel diseases: a retrospective long-term study. European Journal of Gastroenterology & Hepatology 2026; doi: 10.1097/MEG.0000000000003296
|
| 2 |
Nouran Magdy Moustafa, Yafa Abusamak, Shahed Olayan, Lamia Almarjan, Zahra Almubireek, Reema Alfaleet, Rania Alam El-Din Mohamed. Prevalence, Risk Factors, and Clinical Outcome of Clostridium difficile Infection among Patients with Inflammatory Bowel Disease in a Tertiary Hospital in Saudi Arabia. Journal of Pure and Applied Microbiology 2026; 20(3) doi: 10.22207/JPAM.20.3.28
|
| 3 |
Matthias Van Hul, Patrice D. Cani. From microbiome to metabolism: Bridging a two-decade translational gap. Cell Metabolism 2026; 38(1) doi: 10.1016/j.cmet.2025.10.011
|